Corcoran et al v. CVS Health Corporation

Northern District of California, cand-4:2015-cv-03504

ORDER [*AS MODIFIED BY THE COURT*] by Judge Yvonne Gonzalez Rogers granting in part 302 Administrative Motion to File Under Seal.

Interested in this case?

Current View

Full Text

1 UNITED STATES DISTRICT COURT 2 NORTHERN DISTRICT OF CALIFORNIA 3 OAKLAND DIVISION 4 CHRISTOPHER CORCORAN, et al., No. 15-CV-03504-YGR 5 Plaintiffs, [PROPOSED] ORDER GRANTING, IN 6 PART, PLAINTIFFS' ADMINISTRATIVE v. MOTION TO FILE UNDER SEAL 7 MATERIALS DESIGNATED AS CVS PHARMACY, INC., CONFIDENTIAL [DKT. NO. 302] 8 Defendant. Re: Dkt. No. 302 9 *AS MODIFIED BY THE COURT* 10 11 Plaintiffs filed an Administrative Motion to File Under Seal Materials Designated as 12 Confidential ("Motion to Seal") in the above-captioned action on June 6, 2017 pursuant to Local 13 Rules 7-11 and 79-5. See Dkt. No. 302. 14 The Court, having considered Plaintiffs' Motion to Seal, all papers and evidence 15 submitted in support, the pertinent pleadings, and the applicable law, and finding compelling 16 reasons and good cause therefore, hereby GRANTS IN PART the Motion to Seal. It is 17 ORDERED that the following materials are to be filed under seal pursuant to Civil Local Rule 18 79-5(b) and (e): 19 20 Document or Portion of Evidence Offered in Support of Order Document Sought to Be Sealed Sealing 21 GRANT IN Plaintiffs' Opposition to CVS Moffatt Declaration (June 22, 2017) PART, except 22 Pharmacy, Inc.'s Motion for ("Moffatt Decl.") ¶¶ 4(a), (b) 4:5–28, 12:26– 23 13:2 Summary Judgment 24 ("Opposition") at page 4:5- 25 28; 8:7-11; 8:15-19; 12:26- 26 13:2; 13:9-12 27 GRANT Plaintiffs' Responsive Statement Moffatt Decl. ¶ 5 28 [PROPOSED] ORDER GRANTING -1- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 of Facts ("Plaintiffs' SOF") 2 at page 20:21-25 3 GRANT IN PX-767 (Expert Report of Moffatt Decl. ¶ 6 PART, except as 4 Professor Joel W. Hay, PhD to paragraph 43. 5 (Dec. 9, 2016)) ("Hay Report") 6 at paragraphs 33-35, 39, 42, 43, 7 63, 64, and 67; footnote 16 8 GRANT PX-769 (Rebuttal Report of Moffatt Decl. ¶ 7. 9 Professor Joel W. Hay, PhD 10 (Jan. 27, 2017)) ("Hay Rebuttal 11 Report") at paragraphs 40, 42- 12 44, and footnote 24 13 GRANT PX-800 (Amended and Moffatt Decl.¶ 8 14 Supplemented Expert 15 Declaration of Professor Joel W. 16 Hay, PhD. (June 6, 2017)) 17 ("Amended Hay Decl.") at pages 18 5:11–13, and Exhibits C and D 19 GRANT IN PX-803 (Amended and Moffatt Decl.¶¶ 9(a), (b), (c) PART, except as 20 Supplemented Expert to paragraphs 21 38, 42, 44, and Declaration of Robert P. footnotes 30, 22 43, 53 Navarro, Pharm. D. (June 6, 23 2017)) ("Amended Navarro 24 Decl.") at footnote 19 and 25 paragraph 62; paragraphs 38, 42, 26 and 44, and footnotes 30, 43, and 27 53; and footnote 72 28 [PROPOSED] ORDER GRANTING -2- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 GRANT IN PX-809 (Declaration of Moffatt Decl. ¶ 10 PART, except as 2 to paragraph 42. Professor Joel W. Hay, PhD 3 (Oct. 3, 2016)) ("Hay Decl.") at 4 paragraphs 32-34, 38, 42, 52, and 5 53 6 GRANT PX-810 (Rebuttal Declaration of Moffatt Decl. ¶ 11 7 Professor Joel W. Hay, PhD 8 (Jan. 9, 2017)) ("Hay Rebuttal 9 Decl.") at paragraphs 45, 46, 49, 10 and footnote 16 11 GRANT PX-11 (Cash Discount RX Moffatt Decl. ¶ 12(a) 12 Program, BPC Discussion) 13 GRANT PX-28 (Retail Pricing Review Moffatt Decl. ¶ 12(b) 14 Presentation) 15 GRANT PX-42 (Email re CVS Caremark Moffatt Decl. ¶ 12(c) 16 Cash Offering) 17 GRANT PX-47 (ROPP-58 CVS/HSP Moffatt Decl. ¶ 12(d) 18 Policy and Procedure) 19 GRANT PX-83 (HSP Reconciliation Moffatt Decl. ¶ 12(e) 20 Process Policy and 21 Procedure) 22 GRANT PX-254 (CVS Pharmacy Moffatt Decl. ¶ 12(f) 23 Landscape Strategy 24 Document) 25 GRANT IN PX-335 (Third Party Contract Moffatt Decl. ¶ 12(g) PART, except as 26 Administration Policy and to sections 27 relating to: 1) Procedure) Usual & 28 [PROPOSED] ORDER GRANTING -3- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 Customary definitions and 2 provisions; and 3 2) Third-Party beneficiaries 4 DENY PX-827 (Deposition of Robert Moffatt Decl. ¶ 12(h) 5 Greenwood (Sept. 28, 2013)) 6 GRANT IN PX-20 (Meridian Rx LLC-CVS Moffatt Decl.¶ 13(a) PART, except as 7 to sections contract) relating to: 1) 8 Usual & 9 Customary definitions and 10 provisions; and 2) Third-Party 11 beneficiaries 12 GRANT IN PX-164 (Business Case from Moffatt Decl.¶ 13(b) PART, except as 13 Scriptsave) to sections relating to: 1) 14 Usual & Customary 15 definitions and 16 provisions; and 2) Third-Party 17 beneficiaries GRANT IN 18 PX-239 (Email re Medco Moffatt Decl.¶ 13(c) PART, except as Provider Manual) to sections 19 relating to: 1) 20 Usual & Customary 21 definitions and provisions; and 22 2) Third-Party beneficiaries 23 GRANT IN PX-285 (Spreadsheet of Plans) Moffatt Decl.¶ 13(d) PART, except as 24 to sections 25 relating to: 1) Usual & 26 Customary 27 definitions and provisions; and 28 2) Third-Party [PROPOSED] ORDER GRANTING -4- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 beneficiaries GRANT IN 2 PX-530 (Aetna-CVS contract) Moffatt Decl.¶ 13(e) PART, except as 3 to sections relating to: 1) 4 Usual & Customary 5 definitions and provisions; and 6 2) Third-Party 7 beneficiaries GRANT IN 8 PX-532 (Express Scripts-CVS Moffatt Decl.¶ 13(f) PART, except as contract) to sections 9 relating to: 1) Usual & 10 Customary 11 definitions and provisions; and 12 2) Third-Party beneficiaries 13 GRANT IN PX-541 (Optum-CVS contract) Moffatt Decl.¶ 13(g) PART, except as 14 to sections 15 relating to: 1) Usual & 16 Customary definitions and 17 provisions; and 18 2) Third-Party beneficiaries 19 GRANT IN PX-546 (Caremark-CVS Moffatt Decl.¶ 13(h) PART, except as 20 to sections contract) relating to: 1) 21 Usual & 22 Customary definitions and 23 provisions; and 2) Third-Party 24 beneficiaries 25 GRANT IN PX-676 (MedImpact-CVS Moffatt Decl.¶ 13(i) PART, except as 26 contract) to sections relating to: 1) 27 Usual & Customary 28 [PROPOSED] ORDER GRANTING -5- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 definitions and provisions; and 2 2) Third-Party 3 beneficiaries GRANT IN PX-677 (Medco-CVS contract) Moffatt Decl.¶ 13(j) PART, except as 4 to sections 5 relating to: 1) Usual & 6 Customary 7 definitions and provisions; and 8 2) Third-Party beneficiaries 9 GRANT IN PX-685 (Medco 2009/2010 Moffatt Decl.¶ 13(k) PART, except as 10 Pharmacy Services Manual) to sections 11 relating to: 1) Usual & 12 Customary definitions and 13 provisions; and 14 2) Third-Party beneficiaries 15 16 It is further ORDERED that the following materials are to be filed on the public docket 17 without redaction within five business days. For these materials, the Designating Party of the 18 allegedly confidential information therein has stated that the materials need not be redacted or 19 filed under seal. 20 21 Document or Portion of Document Order 22 Opposition at pages 5:15-18; 6:6, GRANT 23 10, 12, 14, 15; 7:1-2; 7:9-8:2; 24 8:4-7, 13-14; 12:20-22, 23-25; 25 15:4-5; and 15:16-16:1; and 26 footnotes 15, 16, 22, 25, 31-33, 27 35-39, and 51 28 [PROPOSED] ORDER GRANTING -6- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 Plaintiffs' SOF at pages 1:7-9, 17- GRANT 2 19; 2:15-16; 3:4-6, 9-11, 25-27; 3 3:28-4:1; 4:6-11, 14, 22-24; 5:2- 4 4; 20:3-5 5 Plaintiffs' Opposition to CVS GRANT 6 Pharmacy, Inc.'s Motion to 7 Exclude the Opinion Testimony 8 of Dr. Joel Hay (June 20, 2017) 9 in its entirety 10 Hay Report at paragraphs 32, 40, 41, GRANT 11 44, 45-53, 62, 65, 66, 68, and 12 71-74; subheadings IV.A.i-iii, 13 IV.C, IV.E, IV.F, and IV.F.i.; 14 and footnotes 9, 11, 15, 19, and 15 27; and tables 1-20 16 Hay Rebuttal Report at paragraphs GRANT 17 7–11, 19–21, 23–29, 31, 36, 39, 18 47, and 48; and tables 1–7 19 Amended Hay Decl. at pages 1:7– GRANT 20 10; 6:13–15, 27; 7:4–6; paragraphs 21 10, 11, and 22; headings II.C.–II.D.; 22 and tables 1–4 23 Amended Navarro Decl. at page 1 GRANT 24 headings III.A–F; paragraphs 25, 30, 25 36–37, 39–41, 43, 45–48 and 26 associated headings/subheadings, 27 49, 52, 53, 60, 70, 73, and 77; 28 [PROPOSED] ORDER GRANTING -7- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 footnotes 27, 45, and 75 2 Hay Decl. at paragraphs 31, 35, 40, GRANT 3 41, 43, 54, 55, 61; subheadings 4 IV.A.ii.–iii.; footnotes 10 and 14; 5 and tables 1–17 6 Hay Rebuttal Decl. at paragraphs 7– GRANT 7 11, 13–15, 19, 20, 21, 24–27, 30–34, 8 36, 38, 50, and 59; subheadings 9 III.G.–III.H.; footnotes 2, 4, 10, and 10 20; and tables 1–5 and 7–22 11 PX-804 (Deposition of Hilary GRANT 12 Dudley (30(b)(6) (Sept. 20, 2016)) 13 PX-807 (Examination Under Oath of GRANT 14 Thomas Morrison (Feb. 2, 2016)) 15 PX-821 (Examination Under Oath of GRANT 16 Paul Ferschke (Dec. 19, 2014)) 17 PX-822 (Deposition of Joel W. Hay GRANT 18 (Nov. 9, 2016)) 19 PX-823 (Deposition of Joel W. Hay GRANT 20 (Mar. 17, 2017)) 21 PX-36 (Email re U&C Definitions GRANT 22 for Beth Wingate (Feb. 12, 2009)) 23 PX-40 (Email re Cash Card GRANT 24 Discussion with Larry (Apr. 9, 25 2008)) 26 PX-58 (Email re Update on Morning GRANT 27 Meetings (Feb. 11, 2008)) 28 [PROPOSED] ORDER GRANTING -8- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR 1 PX-59 (Email re Slide Changes GRANT 2 (Feb. 22, 2008)) 3 PX-60 (Email re Cash Card (May GRANT 4 14, 2008)) 5 PX-163 (Business Case from GRANT 6 ScriptSave (Dec. 9, 2012)) 7 PX-251 (Email re ScriptSave pitch GRANT 8 (Jan. 25, 2013)) 9 PX-831 (Deposition of Thomas GRANT 10 Gibbons (Dec. 13, 2016)) 11 PX-840 (Plaintiffs' Omnibus GRANT 12 Supplemental Responses and 13 Objections to CVS's First 14 Interrogatories (Feb. 24, 2017)) 15 16 This Order terminates Docket Number 302. 17 IT IS SO ORDERED. 18 Dated: ______________ September 5, 2017 ______________________ Hon. Yvonne Gonzalez Rogers 19 United States District Court 20 21 22 23 24 25 26 27 28 [PROPOSED] ORDER GRANTING -9- ADMINISTRATIVE MOTION TO FILE UNDER SEAL DKT. NO. 302, NO. 15-CV-03504-YGR